TransPyloric Shuttle: A non-surgical device to treat obesity - Dream Health

Dream Health aims to provide latest information about health, alternative medicine, fitness, yoga and meditation to improve knowledge and life style.

Recent Posts

Wednesday 1 May 2019

TransPyloric Shuttle: A non-surgical device to treat obesity

TransPyloric Shuttle
TransPyloric Shuttle is an intragastric balloon which is approved by FDA for sale in the US. It is like other intragastric balloons, but the working is completely different. It gives the feeling of being satiated.

People are using gastric balloons to lose weight. Though these gastric balloons give the feeling of a full stomach, they just occupy space and are not very useful.

On the other hand, TransPyloric Shuttle works differently from other gastric balloons. TransPyloricShuttle is an intragastric balloon from BAROnova. They are a company which is based in San Carlos, California. The TransPyloric Shuttle has already received the approval of FDA.

What is TransPyloric Shuttle? 

TPS is a non-surgical device to treat obesity. It is a weight loss solution for adults who are obese and have a body mass index of 30 to 40 kg/m².

BAROnova, a company based in San Carlos, California says that the device covers 12 months of treatment. It involves counselling a person to modify their lifestyle so that they can develop and maintain healthier eating habits.

It is a non-invasive device. It is delivered and retrieved endoscopically through the esophagus. The device consists of a mechanical structure to maintain its shape and keep it in the stomach.

The TransPyloric Shuttle is about 5.6 cm in diameter. This is approximately 85% to 90% smaller than other fluid filled balloons.

The basic aim of this weight loss device is to make the person feel full sooner and stay full for a longer period of time. This happens since it slows the passage of food.

How does the TransPyloric Shuttle work? 

TheTPS is delivered through the esophagus. Within fifteen minutes, the device is assembled in the stomach and takes the shape of a drop. The two ends of the TransPyloric Shuttle then straddle the pyloric sphincter, through which the food exits.

After some food passes through, the natural movement of the stomach forces the device to block the sphincter. A little while later, the TransPyloric Shuttle moves away from the opening of the sphincter, thus allowing some more food to pass through.

The food is not allowed to pass quickly from the stomach through the sphincter. With the result, the stomach remains full for a longer period and the person does not experience hunger pangs.

Removal of the TransPyloric Shuttle involves a simple fifteen minute procedure.

Getting the FDA approval was a significant milestone achieved by BAROnova. They got the approval based on data that was obtained from 302 patient ENDObesity II trial of the TransPyloric Shuttle. They used the data to verify the effectiveness and safety of the device in treating patients who were obese with a body mass index between 30 to 40 kg/m². Besides losing weight, there was also marked cardio-metabolic improvements seen in the patients.

With the TransPyloric Shuttle, patients who are not eligible or unwilling to undergo bariatric surgery can be treated for obesity. The TransPyloric Shuttle offers an alternative treatment for obesity by means of endoscopically delivered intragastric device.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.